Simplex Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.7M | Sell |
2,587,600
-1,148,800
| -31% | -$30.6M | 0.05% | 157 |
|
|
2025
Q4 | $93M | Sell |
3,736,400
-245,100
| -6% | -$6.18M | 0.05% | 165 |
|
|
2025
Q3 | $101M | Sell |
3,981,500
-42,900
| -1% | -$1.06M | 0.05% | 186 |
|
|
2025
Q2 | $97.6M | Sell |
4,024,400
-627,400
| -13% | -$14.6M | 0.06% | 164 |
|
|
2025
Q1 | $118M | Sell |
4,651,800
-390,200
| -8% | -$10.2M | 0.08% | 124 |
|
|
2024
Q4 | $134M | Sell |
5,042,000
-428,700
| -8% | -$11.6M | 0.07% | 133 |
|
|
2024
Q3 | $158M | Sell |
5,470,700
-335,400
| -6% | -$9.78M | 0.09% | 101 |
|
|
2024
Q2 | $162M | Sell |
5,806,100
-914,300
| -14% | -$25.2M | 0.1% | 90 |
|
|
2024
Q1 | $186M | Buy |
6,720,400
+1,674,100
| +33% | +$46.5M | 0.11% | 85 |
|
|
2023
Q4 | $145M | Buy |
5,046,300
+2,204,800
| +78% | +$66.7M | 0.09% | 110 |
|
|
2023
Q3 | $94.3M | Buy |
2,841,500
+448,000
| +19% | +$15.8M | 0.07% | 145 |
|
|
2023
Q2 | $87.8M | Buy |
2,393,500
+668,400
| +39% | +$26M | 0.07% | 163 |
|
|
2023
Q1 | $70.4M | Sell |
1,725,100
-963,300
| -36% | -$41.6M | 0.06% | 218 |
|
|
2022
Q4 | $133M | Buy |
2,688,400
+271,300
| +11% | +$13M | 0.15% | 98 |
|
|
2022
Q3 | $102M | Sell |
2,417,100
-245,500
| -9% | -$11.9M | 0.12% | 114 |
|
|
2022
Q2 | $128M | Sell |
2,662,600
-1,525,200
| -36% | -$77.7M | 0.14% | 81 |
|
|
2022
Q1 | $205M | Buy |
4,187,800
+445,000
| +12% | +$23.1M | 0.19% | 61 |
|
|
2021
Q4 | $196M | Buy |
3,742,800
+118,700
| +3% | +$5.88M | 0.2% | 72 |
|
|
2021
Q3 | $123M | Buy |
3,624,100
+32,500
| +0.9% | +$1.44M | 0.11% | 111 |
|
|
2021
Q2 | $121M | Buy |
3,591,600
+3,559,666
| +11,147% | +$138M | 0.12% | 110 |
|
|
2021
Q1 | $86.7M | Buy |
31,934
+9,102
| +40% | +$323K | 0.16% | 83 |
|
|
2020
Q4 | $34.8M | Buy |
22,832
+5,356
| +31% | +$196K | 0.05% | 234 |
|
|
2020
Q3 | $60.9M | Buy |
17,476
+3,294
| +23% | +$115K | 0.08% | 136 |
|
|
2020
Q2 | $44M | Buy |
14,182
+7,797
| +122% | +$265K | 0.07% | 154 |
|
|
2020
Q1 | $19.8M | Buy |
6,385
+1,133
| +22% | +$38.6K | 0.03% | 241 |
|
|
2019
Q4 | $19.5M | Sell |
5,252
-1,782
| -25% | -$63.5K | 0.04% | 278 |
|
|
2019
Q3 | $24M | Buy |
7,034
+386
| +6% | +$14K | 0.07% | 210 |
|
|
2019
Q2 | $27.3M | Buy |
6,648
+1,080
| +19% | +$42.9K | 0.07% | 179 |
|
|
2019
Q1 | $22.4M | Buy |
5,568
+622
| +13% | +$24.9K | 0.06% | 194 |
|
|
2018
Q4 | $20.5M | Buy |
4,946
+3,090
| +166% | +$128K | 0.06% | 197 |
|
|
2018
Q3 | $7.76M | Sell |
1,856
-39
| -2% | -$1.5K | 0.02% | 447 |
|
|
2018
Q2 | $6.52M | Sell |
1,895
-1,070
| -36% | -$36.6K | 0.03% | 468 |
|
|
2018
Q1 | $430K | Buy |
2,965
+1,705
| +135% | +$58.6K | 0.02% | 789 |
|
|
2017
Q4 | $62K | Sell |
1,260
-876
| -41% | -$29.9K | ﹤0.01% | 2236 |
|
|
2017
Q3 | $221K | Sell |
2,136
-2,934
| -58% | -$94.3K | 0.01% | 1128 |
|
|
2017
Q2 | $647K | Buy |
5,070
+1,983
| +64% | +$62.5K | 0.03% | 530 |
|
|
2017
Q1 | $366K | Sell |
3,087
-632
| -17% | -$19.9K | 0.02% | 853 |
|
|
2016
Q4 | $585K | Buy |
3,719
+1,715
| +86% | +$52.4K | 0.04% | 467 |
|
|
2016
Q3 | $326K | Sell |
2,004
-1,143
| -36% | -$38.2K | 0.02% | 726 |
|
|
2016
Q2 | $251K | Sell |
3,147
-6,195
| -66% | -$198K | 0.02% | 867 |
|
|
2016
Q1 | $1.73M | Buy |
9,342
+4,087
| +78% | +$117K | 0.14% | 135 |
|
|
2015
Q4 | $903K | Buy |
5,255
+2,550
| +94% | +$80.2K | 0.07% | 244 |
|
|
2015
Q3 | $188K | Buy |
2,705
+2,368
| +703% | +$75.9K | 0.01% | 955 |
|
|
2015
Q2 | $26K | Buy |
337
+123
| +57% | +$4.01K | ﹤0.01% | 2234 |
|
|
2015
Q1 | $14K | Sell |
214
-7
| -3% | -$223 | ﹤0.01% | 2633 |
|
|
2014
Q4 | $76K | Buy |
+221
| New | +$6.34K | 0.01% | 1098 |
|
Other funds holding PFE
VCM
VPM
Simplex Trading's PFE Position: Q1 2026 in Review
Simplex Trading reduced its Pfizer (PFE) stake by 15% in Q1 2026, selling an estimated $5.97M and leaving 1,266,685 shares worth $35.6M. The position accounts for 0.02% of the portfolio, ranked #292.
Simplex Trading first reported a position in PFE in Q2 2015 and has held it in 34 quarters since. The position peaked at $128M in Q1 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Simplex Trading held 1,266,685 shares of Pfizer worth $35.6M as of Q1 2026.
- Simplex Trading sold 224,352 Pfizer shares in Q1 2026, an estimated $5.97M.
- Pfizer made up 0.02% of Simplex Trading's portfolio in Q1 2026, its #292 holding.
- Simplex Trading first reported a position in Pfizer in Q2 2015 and has held it in 34 quarters since.
- Simplex Trading's Pfizer position peaked at $128M in Q1 2024.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.